Variation in the Biochemical/Biophysical Properties of Mutant Superoxide Dismutase 1 Enzymes and the Rate of Disease Progression in Familial Amyotrophic Lateral Sclerosis Kindreds
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Mutations in superoxide dismutase 1 (SOD1) polypeptides cause a form of familial amyotrophic lateral sclerosis (FALS). In different kindreds, harboring different mutations, the duration of illness tends to be similar for a given mutation. For example, patients inheriting a substitution of valine for alanine at position four (A4V) average a 1.5 year life expectancy after the onset of symptoms, whereas patients harboring a substitution of arginine for histidine at position 46 (H46R) average an 18 year life expectancy after disease onset. Here, we examine a number of biochemical and biophysical properties of nine different FALS variants of SOD1 polypeptides, including enzymatic activity (which relates indirectly to the affinity of the enzyme for copper), polypeptide half-life, resistance to proteolytic degradation and solubility, in an effort to determine whether a specific property of these enzymes correlates with clinical progression. We find that although all the mutants tested appear to be soluble, the different mutants show a remarkable degree of variation with respect to activity, polypeptide half-life and resistance to proteolysis. However, these variables do not stratify in a manner that correlates with clinical progression. We conclude that the basis for the different life expectancies of patients in different kindreds of sod1-linked FALS may result from an as yet unidentified property of these mutant enzymes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McCord, J. M., & Fridovich, I. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)63504-5 · Cited by 12,952 · cited 1×
“Portions of these lysates were assayed for SOD1 a ity in solution as described previously (62).”
MethodSuperoxide dismutase: Improved assays and an assay applicable to acrylamide gels
Beauchamp, C., & Fridovich, I. (1971) · Analytical Biochemistry · doi:10.1016/0003-2697(71)90370-8 · Cited by 12,892 · cited 1×
“The activity of the enzymes was then assayed in these gels as described previously ( 59 ).”
MethodRosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062 · cited 1×
“Although the etiology of the more common ‘sporadic’ form of ALS is not well defined, mutations in sod1 have been associated with a subset of inherited cases (3, 4 ).”
BackgroundGlenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
High-efficiency transformation of mammalian cells by plasmid DNA.
Chen, C., & Okayama, H. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2745 · Cited by 5,373 · cited 1×
“Confluent 60 mm dishes COS-1 cells were transfected with 5 μg of expression plasmid, following previously described procedures (58).”
MethodAmyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143 · cited 1×
“High level expression of wild-type human (Hu) SOD1 polypeptides does not cause disease ( 10 ,11).”
BackgroundpEF-BOS, a powerful mammalian expression vector
Mizushima, S., & Nagata, S. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.17.5322 · Cited by 1,605 · cited 1×
“The expression plasmids for transfection of mammalian cells were generated with the pEF.BOS vector ( 55 ).”
MethodAmyotrophic Lateral Ssclerosis and Structural Defects in Cu,Zn Superoxide Dismutase
Deng, H.-X., Hentati, A., Tainer, J. A., Iqbal, Z., Cayabyab, A., Hung, W.-Y., Getzoff, E. D., Hu, P., Herzfeldt, B., Roos, R. P., et al. (1993) · Science · doi:10.1126/science.8351519 · Cited by 1,477 · cited 1×
“Although the etiology of the more common ‘sporadic’ form of ALS is not well defined, mutations in sod1 have been associated with a subset of inherited cases ( 3 ,4).”
BackgroundWong, P. C., Pardo, C. A., Borchelt, D. R., Lee, M. K., Copeland, N. G., Jenkins, N. A., Sisodia, S. S., Cleveland, D. W., & Price, D. L. (1995) · Neuron · doi:10.1016/0896-6273(95)90259-7 · Cited by 1,445 · cited 5×
“Similar inclusions, although more rare, have been seen in the cell bodies and proximal axons of spinal motor neurons in mice expressing the G37R variant ( 11 ,26).”
BackgroundSelf-citationBruijn, L. I., Becher, M. W., Lee, M. K., Anderson, K. L., Jenkins, N. A., Copeland, N. G., Sisodia, S. S., Rothstein, J. D., Borchelt, D. R., Price, D. L., et al. (1997) · Neuron · doi:10.1016/s0896-6273(00)80272-x · Cited by 1,341 · cited 8×
“Thus, it is not clear whether the clustering of SOD1 immunoreactivity that has been described in affected tissues of transgenic mice (11, 12 ,26,27) and FALS patients represents a true aggregation.”
BackgroundSelf-citationReaume, A. G., Elliott, J. L., Hoffman, E. K., Kowall, N. W., Ferrante, R. J., Siwek, D. R., Wilcox, H. M., Flood, D. G., Beal, M. F., Brown, R. H., et al. (1996) · Nature Genetics · doi:10.1038/ng0596-43 · Cited by 1,292 · cited 1×
“For example, the targeted deletion of sod1 in mice does not lead to developmental defects or cause motor neuron disease ( 14 ).”
BackgroundAggregation and Motor Neuron Toxicity of an ALS-Linked SOD1 Mutant Independent from Wild-Type SOD1
Bruijn, L. I., Houseweart, M. K., Kato, S., Anderson, K. L., Anderson, S. D., Ohama, E., Reaume, A. G., Scott, R. W., & Cleveland, D. W. (1998) · Science · doi:10.1126/science.281.5384.1851 · Cited by 1,228 · cited 5×
“If Cu chemistry is not involved in the disease, then what a the alternatives? The prevalence of SOD1-immunoreact inclusions in transgenic mice expressing FALS varian (11,12,26,27) and a subset of human sod1-linked FALS cases (12,27,28) has led to the suggestion that mutant enzymes m aggregate (12,27,52).”
BackgroundSelf-citationA protease-resistant protein is a structural component of the Scrapie prion
McKinley, M. P., Bolton, D. C., & Prusiner, S. B. (1983) · Cell · doi:10.1016/0092-8674(83)90207-6 · Cited by 917 · cited 1×
“In other disorders, such as the prion diseases and Alzheimer’s disease, prion proteins ( 30 ,31) and β-amyloid peptides (32‐34) form sedimentable aggregates.”
BackgroundBeckman, J. S., Carson, M., Smith, C. D., & Koppenol, W. H. (1993) · Nature · doi:10.1038/364584a0 · Cited by 870
The Copper Chaperone for Superoxide Dismutase
Culotta, V. C., Klomp, L. W. J., Strain, J., Casareno, R. L. B., Krems, B., & Gitlin, J. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.38.23469 · Cited by 850 · cited 2×
“However, it has becom clear recently that proteins, termed copper chaperones, required to load SOD1 enzyme with its Cu 2+ cofactor (48), and, thus, the data fromE.”
BackgroundMethodSelf-citationKinetics of superoxide dismutase- and iron-catalyzed nitration of phenolics by peroxynitrite
Beckman, J. S., Ischiropoulos, H., Zhu, L., van der Woerd, M., Smith, C., Chen, J., Harrison, J., Martin, J. C., & Tsai, M. (1992) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(92)90432-v · Cited by 764
Ripps, M. E., Huntley, G. W., Hof, P. R., Morrison, J. H., & Gordon, J. W. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.689 · Cited by 722
Altered Reactivity of Superoxide Dismutase in Familial Amyotrophic Lateral Sclerosis
Wiedau-Pazos, M., Goto, J. J., Rabizadeh, S., Gralla, E. B., Roe, J. A., Lee, M. K., Valentine, J. S., & Bredesen, D. E. (1996) · Science · doi:10.1126/science.271.5248.515 · Cited by 719 · cited 1×
“One hypothesis suggests that the mutations may enhance the ability of the enzyme to react with H 2O2 (41,42), leading to increased levels of hydroxyl radical and oxidative damage.”
BackgroundBorchelt, D. R., Lee, M. K., Slunt, H. S., Guarnieri, M., Xu, Z. S., Wong, P. C., Brown, R. H., Price, D. L., Sisodia, S. S., & Cleveland, D. W. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.17.8292 · Cited by 621 · cited 10×
“For example, many FALS-associated mutations not substantially reduce enzymatic activity in in vitro assays (7).”
BackgroundMethodSelf-citationSuperoxide Dismutase from Escherichia coli B
Keele, B. B., McCord, J. M., & Fridovich, I. (1970) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)62675-4 · Cited by 559
Epidemiology of mutations in superoxide dismutase in amyotrophic lateal sclerosis
Cudkowicz, M. E., McKenna‐Yasek, D., Sapp, P. E., Chin, W., Geller, B., Hayden, D. L., Schoenfeld, D. A., Hosler, B. A., Horvitz, H. R., & Brown, R. H. (1997) · Annals of Neurology · doi:10.1002/ana.410410212 · Cited by 533
Crow, J. P., Sampson, J. B., Zhuang, Y., Thompson, J. A., & Beckman, J. S. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69051936.x · Cited by 485
Yim, M. B., Kang, J. H., Yim, H. S., Kwak, H. S., Chock, P. B., & Stadtman, E. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5709 · Cited by 458 · cited 1×
“One hypothesis suggests that the mutations may enhance the ability of the enzyme to react with H2O2 (41, 42 ), leading to increased levels of hydroxyl radical and oxidative damage.”
BackgroundDal Canto, M. C., & Gurney, M. E. (1995) · Brain Research · doi:10.1016/0006-8993(95)00063-v · Cited by 435 · cited 1×
“For example, the dying motor neurons of mice expressing high levels of the G37R and G93A mutants show predominantly vacuolar pathology that appears to result from the swelling of mitochondrial and endoplasmic reticulum membranes (11, 35 ,36).”
BackgroundAn Iron-containing Superoxide Dismutase from Escherichia coli
Yost, F. J., & Fridovich, I. (1973) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)43649-1 · Cited by 388 · cited 1×
“coli may not be relevant, as bacterial an mammalian SOD1 enzymes utilize different metal cofacto (49,50).”
BackgroundAmyotrophic lateral sclerosis: Recent insights from genetics and transgenic mice
Brown, R. H. (1995) · Cell · doi:10.1016/0092-8674(95)90346-1 · Cited by 352 · cited 1×
“If Cu chemistry is not involved in the disease, then what are the alternatives? The prevalence of SOD1-immunoreactive inclusions in transgenic mice expressing FALS variants (11,12,26,27) and a subset of human sod1-linked FALS cases (12,27,28) has led to the suggestion that mutant enzymes may aggregate (12,27, 52 ).”
BackgroundAggregation of Mutant Cu/Zn Superoxide Dismutase Proteins in a Culture Model of ALS
DURHAM, H. D., ROY, J., DONG, L., & FIGLEWICZ, D. A. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199705000-00008 · Cited by 349
Rabizadeh, S., Gralla, E. B., Borchelt, D. R., Gwinn, R., Valentine, J. S., Sisodia, S., Wong, P., Lee, M., Hahn, H., & Bredesen, D. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.3024 · Cited by 335 · cited 3×
“In examining the activity of FALS mutants expressed in yeast, we discovered that the G85R variant, which completely rescues the growth of sod1null yeast (8,13) and shows activity in solution assays of yeast extracts (Fig.”
BackgroundSelf-citationAndersen, P. M., Nilsson, P., Ala-Hurula, V., Keränen, M.-L., Tarvainen, I., Haltia, T., Nilsson, L., Binzer, M., Forsgren, L., & Marklund, S. L. (1995) · Nature Genetics · doi:10.1038/ng0595-61 · Cited by 322 · cited 1×
“In Swedish kindreds with the D90A mutation in sod1, the disease is inherited in an autosomal recessive manner and exhibits partial penetrance ( 38 ).”
BackgroundPardo, C. A., Xu, Z., Borchelt, D. R., Price, D. L., Sisodia, S. S., & Cleveland, D. W. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.954 · Cited by 314 · cited 1×
“The M/H SOD1 antibody was raised against a synthetic peptide that is identical in seque in mouse and human SOD1 polypeptide (7,57).”
BackgroundSelf-citationAtomic structures of wild-type and thermostable mutant recombinant human Cu,Zn superoxide dismutase.
Parge, H. E., Hallewell, R. A., & Tainer, J. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.13.6109 · Cited by 304 · cited 2×
“Histidine residues 46 and 48 are two of four histidines th coordinately bind the Cu 2+ cofactor (19), and in two kindreds of FALS these residues are mutated to arginine and glutam r spectively (20,21).”
BackgroundShibata, N., Hirano, A., Kobayashi, M., Siddique, T., Deng, H.-X., Hung, W.-Y., Kato, T., & Asayama, K. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199604000-00011 · Cited by 293 · cited 1×
“Spinal cord section patients harboringsod1alleles with the A4V mutation (28) and the FS126 mutation (27,29) show motor neurons filled wi SOD1 immunoreactivity.”
BackgroundBruening, W., Roy, J., Giasson, B., Figlewicz, D. A., Mushynski, W. E., & Durham, H. D. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720693.x · Cited by 263 · cited 1×
“Recent immunocytochemical studies cells transfected with FALS variants of SOD1 suggest th mutant enzyme may form cytoplasmic aggregates when ov expressed in embryonic motor neurons (53) and that c expression of heat shock protein 70 ameliorates both SOD mediated toxicity and SOD1 aggregation (54).”
BackgroundCrow, J. P., Ye, Y. Z., Strong, M., Kirk, M., Barnes, S., & Beckman, J. S. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69051945.x · Cited by 260
Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis
McKinley, M. P., Meyer, R. K., Kenaga, L., Rahbar, F., Cotter, R., Serban, A., & Prusiner, S. B. (1991) · Journal of Virology · doi:10.1128/jvi.65.3.1340-1351.1991 · Cited by 257
Amyloidosis: its nature and pathogenesis.
Glenner, G. G., Wd, T., & Isersky, C. (1973) · PubMed · Cited by 217
Juneja, T., Pericak-Vance, M. A., Laing, N. G., Dave, S., & Siddique, T. (1997) · Neurology · doi:10.1212/wnl.48.1.55 · Cited by 196
Canto, M. C. D., & Gurney, M. E. (1997) · Acta Neuropathologica · doi:10.1007/s004010050650 · Cited by 188 · cited 1×
“These comparisons are complicated by the fact that the level of transgene expression plays an important role in the manifestation of pathology: vacuolar pathology is much less prevalent in mice expressing low levels of G93A ( 37 ).”
BackgroundLyons, T. J., Liu, H., Goto, J. J., Nersissian, A., Roe, J. A., Graden, J. A., Café, C., Ellerby, L. M., Bredesen, D. E., Gralla, E. B., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12240 · Cited by 182 · cited 1×
“An examination of purified H46R enzyme suggest that this mutant can bind copper in vitro (51).”
BackgroundCizewski Culotta, V., Joh, H.-D., Lin, S.-J., Hudak Slekar, K., & Strain, J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.50.29991 · Cited by 169 · cited 1×
“In yeast, SOD1 enzyme also play role in maintaining cytosolic Cu 2+ homeostasis (6).”
BackgroundSelf-citationCorson, L. B., Strain, J. J., Culotta, V. C., & Cleveland, D. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6361 · Cited by 160 · cited 8×
“Yeast require as little as 2% of normal levels of SOD1 polypeptides to grow in air in the absence of methionine and lysine ( 13 ).”
BackgroundMethodSelf-citationAl-Chalabi, A. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.13.2045 · Cited by 159 · cited 2×
“Additional mapping studies indicate that some of the dominant kindreds may be related to the recessive kindreds, with a crossover event ~2.5 cM from the sod1 locus distinguishing the recessive and dominant kindreds ( 40 ).”
BackgroundInfluentialRadunovic, A., & Leigh, P. N. (1996) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.61.6.565 · Cited by 155
Borchelt, D. R., Guarnieri, M., Wong, P. C., Lee, M. K., Slunt, H. S., Xu, Z.-S., Sisodia, S. S., Price, D. L., & Cleveland, D. W. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.7.3234 · Cited by 151 · cited 3×
“Mammalian expression plasmids were transfected into COS-1 and mouse neuroblastoma N2a cells as described previously (7,9).”
BackgroundMethodSelf-citationRobberecht, W., Aguirre, T., Van Den Bosch, L., Tilkin, P., Cassiman, J. J., & Matthijs, G. (1996) · Neurology · doi:10.1212/wnl.47.5.1336 · Cited by 129
Multiple Sclerosis. Clinical and pathogenetic basis.
ROBERTSON, N. (1997) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.63.6.815 · Cited by 128
Metals and Oxidative Damage in Neurological Disorders
Connor, J. R. (1997) · Springer eBooks · doi:10.1007/978-1-4899-0197-2 · Cited by 123
Borchelt, D., Wong, P. C., Bêcher, M. W., Pardo, C. A., Lee, M. K., Xu, Z.-S., Thinakaran, G., Jenkins, N. A., Copeland, N. G., Sisodia, S. S., et al. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0178 · Cited by 120 · cited 4×
“In other disorders, such the prion diseases and Alzheimer’s disease, prion proteins (30 andβ-amyloid peptides (32–34) form sedimentable aggregat Thus, it is not clear whether the clustering of SOD1 immunorea tivity that has been described in affected tissues of transgenic m (11,12,26,27) and FALS patients represents a…”
BackgroundSelf-citationToxic mutants in Charcot's sclerosis
Cleveland, D. W., Laing, N. G., Hurse, P. V., & Brown, R. H. (1995) · Nature · doi:10.1038/378342a0 · Cited by 98 · cited 5×
“Because the duration of illness within an sod1-linked FALS kindred appears to be remarkably consistent, it has been suggested that the duration of illness is an indicator of the relative toxicity of the mutant SOD1 enzymes ( 16 ).”
BackgroundSelf-citationCarrì, M. T., Battistoni, A., Polizio, F., Desideri, A., & Rotilio, G. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)01295-4 · Cited by 81 · cited 1×
“A previous study of the ability of the His46 mutant (H46R) to rescue E.coli lacking endogenous SOD1 enzymatic activity suggested that this mutant retains some level of normal activity ( 47 ).”
BackgroundChang, E. C., Crawford, B. F., Hong, Z., Biliński, T., & Kosman, D. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)64338-1 · Cited by 76
Chang, E. C., & Kosman, D. J. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.4.1840-1845.1990 · Cited by 76
Neuronal degeneration in human diseases and animal models
Price, D. L., Martin, L. J., Clatterbuck, R. E., Koliatsos, V. E., Sisodia, S. S., Walker, L. C., & Cork, L. C. (1992) · Journal of Neurobiology · doi:10.1002/neu.480230916 · Cited by 34
Cited by
COPPER-ZINC SUPEROXIDE DISMUTASE AND AMYOTROPHIC LATERAL SCLEROSIS
Valentine, J. S., Doucette, P. A., & Zittin Potter, S. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161647 · Cited by 785
Mattiazzi, M., D'Aurelio, M., Gajewski, C. D., Martushova, K., Kiaei, M., Beal, M. F., & Manfredi, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203065200 · Cited by 616
Toxicity of Familial ALS-Linked SOD1 Mutants from Selective Recruitment to Spinal Mitochondria
Liu, J., Lillo, C., Jonsson, P. A., Velde, C. V., Ward, C. M., Miller, T. M., Subramaniam, J. R., Rothstein, J. D., Marklund, S., Andersen, P. M., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.06.016 · Cited by 506
Self-citationTransgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS
TURNER, B., & TALBOT, K. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.01.001 · Cited by 496
De Vos, K. J., Chapman, A. L., Tennant, M. E., Manser, C., Tudor, E. L., Lau, K.-F., Brownlees, J., Ackerley, S., Shaw, P. J., McLoughlin, D. M., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm226 · Cited by 420
Metadata
- Authors
- Ratovitski, T., Corson, L. B., Strain, J., Wong, P., Cleveland, D. W., Culotta, V. C., & Borchelt, D. R.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-08-01
- Volume
- 8
- Issue
- 8
- Pages
- 1451-1460
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2133408527
- Cited by
- 180
- References
- 54
- FWCI
- 5.19
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.